protoporphyrin ix has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A low dosage of loaded DTX in FA-CD@PP-CpG can promote infiltration of CTLs to improve efficacy of anti-PD-L1 antibody (aPD-L1), suppress MDSCs, and effectively polarize MDSCs toward M1 phenotype to reduce tumor burden, further to enhance the antitumor efficacy." | 1.51 | Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers. ( Chen, L; Dong, C; Han, Y; Hu, X; Liang, S; Lin, Y; Liu, J; Lu, Y; Shi, S; Wang, C; Yao, T; Zhou, L, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Palasuberniam, P | 1 |
| Kraus, D | 1 |
| Mansi, M | 1 |
| Howley, R | 1 |
| Braun, A | 1 |
| Myers, K | 1 |
| Chen, B | 1 |
| Chen, L | 1 |
| Zhou, L | 1 |
| Wang, C | 1 |
| Han, Y | 1 |
| Lu, Y | 1 |
| Liu, J | 1 |
| Hu, X | 1 |
| Yao, T | 1 |
| Lin, Y | 1 |
| Liang, S | 1 |
| Shi, S | 1 |
| Dong, C | 1 |
| Jou, AF | 1 |
| Chou, YT | 1 |
| Willner, I | 1 |
| Ho, JA | 1 |
3 other studies available for protoporphyrin ix and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Topics: Aminolevulinic Acid; Cell Line, Tumor; Fluorescence; Humans; Photochemotherapy; Photosensitizing Age | 2021 |
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Survival; Copper; Docetaxel; Drug | 2019 |
Imaging of Cancer Cells and Dictated Cytotoxicity Using Aptamer-Guided Hybridization Chain Reaction (HCR)-Generated G-Quadruplex Chains.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Cell Proliferation; Cell Survival; Coordination Complex | 2021 |